We specialize in wide genome sequencing tests that can detect 85-90% of all genetic conditions, empowering individuals and healthcare providers with precise results.
Hybrid tests combining qPCR, sequencing, and advanced bioinformatics.
Detects 85-90% of genetic conditions with fewer tests.
Designed to reduce diagnostic costs and time.
Tailored for patients, hospitals, and healthcare providers.
Oncology precision, clinical genetics, and specialized reporting.
Advanced genomic solutions for rare diseases.
At FrontierSeq, we are driven by a simple but profound mission: to make precision medicine accessible, affordable, and transformative for Latin America. Our journey began in Chihuahua, Mexico, as a diagnostics lab founded with a vision to bring cutting-edge molecular diagnostics to our community.
During the COVID-19 pandemic, we were among the first in the region to offer reliable testing, becoming a trusted name in diagnostics when it mattered most. Our partnerships with Mexico’s leading hospital chains revealed a pressing need—doctors needed better tools to provide precision care, yet many of these tools were only available abroad.
Recognizing this gap, FrontierSeq was born—a spinoff created in collaboration with Centinel BioGen, blending expertise and innovation to transform healthcare in LATAM. With over 30 years of combined genomics experience, our founders laid the groundwork for a company that bridges cutting-edge science with the region's healthcare challenges.
Today, FrontierSeq is dedicated to empowering clinicians with faster, more affordable genomic solutions. From advanced diagnostics to tailored treatment strategies, we are pioneering a future where precision medicine is not a privilege but a standard of care.
We are proud of our roots, inspired by our partnerships, and committed to a vision of healthier, more equitable communities across Latin America. At FrontierSeq, the frontier of medicine is here.
We want technology and sequencing analysis to be delivered in an affordable, fast and accurate way
